Eesti -
eesti -
Ravimiamet
valcyte õhukese polümeerikattega tablett
roche eesti osaühing - valgantsikloviir - õhukese polümeerikattega tablett - 450mg 60tk
Eesti -
eesti -
Ravimiamet
equoral 25 mg pehmekapsel
teva b.v. - tsüklosporiin - pehmekapsel - 25mg 50tk
Eesti -
eesti -
Ravimiamet
equoral 100 mg pehmekapsel
teva b.v. - tsüklosporiin - pehmekapsel - 100mg 50tk
Eesti -
eesti -
Ravimiamet
aciclovir actavis tablett
actavis nordic a/s - atsikloviir - tablett - 400mg 10tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
Eesti -
eesti -
Ravimiamet
vedida infusioonilahuse pulber
medochemie limited - vorikonasool - infusioonilahuse pulber - 200mg 1tk
Eesti -
eesti -
Ravimiamet
dotascan süstelahus
farmak international sp. z o.o. - gadoteerhape - süstelahus - 0,5mmol 1ml 10ml 10tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
hyftor
plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
litfulo
pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - immunosupressandid - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.